Ophthalmic Business Council
For more than 25 years, the Foundation has facilitated the Ophthalmic Business Council (OBC) with the goal of fostering communication among leaders in the ophthalmic community. The OBC provides an ideal forum for thought leaders from the Academy, industry, government and health policy to collaborate face-to-face on ways to improve patient care.
OBC members are invited to attend two essential symposia with unparalleled networking opportunities with Academy physician leaders and industry experts.
To join or learn more, contact Todd Lyckberg at 415.447.0361 or tlyckberg@aao.org.
Download brochures: AAO 2022-23 exhibitors and non-exhibitors
Save the Date
Fall 2022 Symposium
Sept. 8-9, 2022
San Francisco, Calif.
Held in conjunction with the Academy’s Board of Trustees meeting, the Fall Symposium covers the most timely and relevant issues facing ophthalmology today. In-depth presentations and open-forum discussions allow you to hear from all perspectives: physician, industry, health policy and government. The Fall Symposium is the perfect way to gain meaningful insights from key players.
Spring 2023 Symposium
Apr. 20, 2023
Washington, DC
The Spring Symposium is held every other year in Washington, D.C. It features experts from government agencies presenting updates on FDA, Medicare and reimbursement issues. As the speed of innovation and new knowledge in ophthalmology grows, this event has become increasingly valuable in providing helpful insights for bringing new technologies and procedures to patients.
Member Benefits
2021 - 2022 Ophthalmic Business Council
Platinum Benefactors ($35,000)
Alcon, Inc.
Biogen
Horizon Therapeutics
Novartis Pharmaceuticals
Crown Benefactors ($25,000)
Allergan, an AbbVie Company
Genentech, Inc.
Regeneron Pharmaceuticals, Inc.
Benefactors ($15,000)
Bausch + Lomb
Johnson & Johnson Vision
Mallinckrodt Pharmaceuticals
Optos, Inc.
Santen, Inc.
Sight Sciences, Inc.
Verana Health
Patrons ($7,500)
Aerie Pharmaceuticals, Inc.
Amgen, Inc.
Bio-Tissue, Inc.
Boehringer Ingelheim
Carl Zeiss Meditec, Inc.
Dompé
EyePoint Pharmaceuticals
Glaukos Corporation
Leadiant Biosciences, Inc.
REGENXBIO, Inc.
Spark Therapeutics, Inc.
Subscribers ($5,000)
Apellis Pharmaceuticals
Ivantis, Inc.
Vyluma
Notal Vision
Sun Ophthalmics
Members ($2,500)
Aura Biosciences, Inc.
Centricity Vision, Inc.
Immunovant, Inc.
Omeros Corporation
W. L. Gore & Associates